Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
Open Access
- 18 December 2007
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (1) , 143-147
Abstract
We analysed the expression of microsatellite instability, p53, p21, vascular endothelial growth factor and thymidylate synthase (TS) in pretreatment biopsy specimens from 57 locally advanced rectal cancers. The aim of the study was to correlate the expression of these markers with pathological response. Nineteen patients were treated with preoperative concomitant radiotherapy (RT) and fluorouracil/oxaliplatin-based chemotherapy (RCT), while 38 had RT alone. Pathological complete remission (pCR) and microfoci residual tumour (micR) occurred more frequently in patients treated with RCT (P=0.002) and in N0 tumours (P=0.004). Among patients treated with RCT, high TS levels were associated with a higher response rate (pCR+micR; P=0.015). No such correlation was found in the RT group. The other molecular factors were of no predictive value. Multivariate analysis confirmed a significant interaction between nodal status and the probability of achieving a pathological response (P=0.023) and between TS expression and treatment, indicating that a high TS level is predictive of a higher pathological response in the RCT subset (P=0.007). This study shows that lymph node status is the most important predictive factor of tumour response to preoperative treatment. Thymidylate synthase expression assessed immunohistochemically from pretreatment tumour biopsies may be a useful predictive marker of rectal tumour response to preoperative RCT.Keywords
This publication has 28 references indexed in Scilit:
- Lymph Node Status and TS Gene Expression Are Prognostic Markers in Stage II/III Rectal Cancer After Neoadjuvant Fluorouracil-Based ChemoradiotherapyJournal of Clinical Oncology, 2006
- Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal CancerJournal of Clinical Oncology, 2006
- VEGF as a predictive marker of rectal tumor response to preoperative radiotherapyCancer, 2005
- A Predictive Model of Rectal Tumor Response to Preoperative Radiotherapy Using Classification and Regression Tree MethodsClinical Cancer Research, 2005
- A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancerAnnals of Oncology, 2005
- Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2004
- Thymidylate Synthase Protein Expression in Primary Colorectal Cancer: Lack of Correlation With Outcome and Response to Fluorouracil in Metastatic Disease SitesJournal of Clinical Oncology, 2003
- Investigation of the Prognostic and Predictive Value of Thymidylate Synthase, p53, and Ki-67 in Patients With Locally Advanced Colon CancerJournal of Clinical Oncology, 2002
- A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significanceCancer, 1998
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997